ENTITY
Acotec Scientific

Acotec Scientific (6669 HK)

57
Analysis
Health Care • China
Acotec Scientific is a medical technology company specializing in the research, development, and application of innovative solutions for vascular diseases. Its core products include drug-coated balloons (DCB) and percutaneous transluminal angioplasty (PTA) balloon catheters, such as AcoArt Orchid & Dhalia. The company was founded in 2008 and is headquartered in Beijing, China.
more
bullish•Osstem Implant
•01 Feb 2023 12:50

(Mostly) Asia M&A, Jan 2023: Essential Metals, Relia Inc, Osstem Implant, Esso Thailand

For the month of January, four new deals were discussed on Smartkarma with an overall announced deal size of ~US$3bn. The average premium for the...

Logo
579 Views
Share
•29 Jan 2023 07:10

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Osstem, Warrego, Norwest Energy, Acotec, Sabana, Jafco, Toyo

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
869 Views
Share
•29 Jan 2023 00:45

Weekly Deals Digest (29 Jan) - AAG Energy, Acotec, Xingda, Origin Energy, Tyro, Kanematsu, Toyo

Last week, notable developments occurred in Event-Driven (AAG Energy, Acotec, Xingda, Kanematsu Electronics, Toyo Construction, Norwest, Origin...

Logo
544 Views
Share
•27 Jan 2023 11:02

Acotec (6669 HK): Current Proration of 82.7%

Acotec has had a great run  -  the implied back-end is up 69% since my last insight. If you're still playing the arb and have yet to tender, sell...

Logo
631 Views
Share
•26 Jan 2023 22:50

Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Unconditional

Based on the current proration of 82.71% and at the last close price of HK$19.78 per share, the breakeven price is HK$19.00 per share.

Logo
654 Views
Share
x